Instytut Badawczo - Rozwojowy Biogened sp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2007-05-21
Share capital
350,000.00 PLN
Registered address
Pojezierska 99, 91-342 Łódź, Poland

Financials

Revenue history (in k)

Filing timeliness

5 of 6 financial statements were filed late (the longest delay 255 days for 2023).

  • 202521/09/2026
  • 202430/09/2025
  • 202327/03/2025
  • 202218/07/2023
  • 202129/09/2022
  • 202029/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 17%
City · Łódź2,312 / 8,064
Top 29%
Voivodeship · Łódzkie5,147 / 15,341
Top 34%
Country · Poland97,000 / 297,566
Top 33%

Results vs industry

Revenue
This companyUSD 871.50kMedianUSD 56.72kAverageUSD 2.72m
Net profit
This companyUSD 450.19kMedianUSD -1.27kAverageUSD -92.87k
Operating costs
This companyUSD 375.50kMedianUSD 66.48kAverageUSD 2.68m
Assets
This companyUSD 2.43mMedianUSD 134.71kAverageUSD 3.04m

Industry

Trademarks

The company holds 19 active trademarks registered with the Polish Patent Office. 1 application is pending. 45 marks have expired or were not registered. The first mark was filed in 1994.

MarkNumberClassesStatusProtected until
DERMEDIC RECOMMENDED BY DERMATOLOGISTS (word)Z.5887823, 5, 35Protected Aug 11, 2035
DF DERMEDIC FRANCE Z.5832263, 5, 35Protected Apr 15, 2035
MELUMIN (word)Z.5701593, 5, 35Protected May 29, 2034
HYDRAIN (word)Z.5657123, 5, 35Protected Feb 5, 2034
CAPILARTE (word)Z.5657113, 5, 35Protected Feb 5, 2034
MarkProtected until
DERMEDIC RECOMMENDED BY DERMATOLOGISTS (word)Aug 11, 2035
DF DERMEDIC FRANCE Apr 15, 2035
MELUMIN (word)May 29, 2034
HYDRAIN (word)Feb 5, 2034
CAPILARTE (word)Feb 5, 2034

Authorized Representatives

Barbara Biegańska age 64 – Attorney-in-fact (sole)
Dorota Cedzyńska age 60 – Attorney-in-fact (sole)
Elżbieta Maria Mikołajczak age 76 – President of the Management Board
Ewa Teresa Rynkowska age 64 – Vice President of the Management Board

Manner of representation

Two members of the management board acting jointly or one member of the management board together with a commercial proxy are authorised to make declarations of will on behalf of the company.

Ownership

OwnerSharesShare valueStake
500$13,506.2114.2857%
Life Science Technologies N.v.
3,000$81,037.2885.7143%

Beneficial owners

Person

Subsidiaries

NameStake
35%

Capital group

The company belongs to the Life Science Technologies N.V. (Netherlands) group, which is its direct owner.

Bank accounts

Registered as a VAT taxpayer on 2007-04-12.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
COS Lab P.S.A.
Syvento sp. z o.o.
WPD Pharmaceuticals sp. z o.o.
RDLS sp. z o.o.
Ecoversea sp. z o.o.
Zakład Genetyki Sądowej sp. z o.o.
Genxone S.A.
Polbiotech Laboratorium sp. z o.o.
Uvera S.A.
Centrum Badań Weterynaryjnych Vetcomplex sp. z o.o.

Change history

DateEvent
2020-09-16Share capital increase
2015-07-20PKD change
2010-11-09Switch to PKD 2007
2007-05-21Entered in the register

FAQ

Last updated: 2026-09-25